Cargando…
Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis
BACKGROUND: Although it is well described among adults, intravenous colistin use and its associated toxicities in newborns are poorly understood. OBJECTIVES: We present our experience of efficacy and safety of intravenous colistin in the treatment of sepsis in term and preterm neonates. PATIENTS AND...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575804/ https://www.ncbi.nlm.nih.gov/pubmed/26396706 http://dx.doi.org/10.5812/ijp.453 |
_version_ | 1782390821080793088 |
---|---|
author | Serafettin Tekgunduz, Kadir Kara, Mustafa Caner, Ibrahim Demirelli, Yasar |
author_facet | Serafettin Tekgunduz, Kadir Kara, Mustafa Caner, Ibrahim Demirelli, Yasar |
author_sort | Serafettin Tekgunduz, Kadir |
collection | PubMed |
description | BACKGROUND: Although it is well described among adults, intravenous colistin use and its associated toxicities in newborns are poorly understood. OBJECTIVES: We present our experience of efficacy and safety of intravenous colistin in the treatment of sepsis in term and preterm neonates. PATIENTS AND METHODS: The records of neonates who received colistin between January 2013 and February 2014 were retrospectively reviewed. All neonates with culture proven nosocomial infections due to multidrug resistant organisms and treated continuously with colistin for more than 72 hours were included in the study. RESULTS: Patients were evaluated for clinical and microbiological response to the drug and its and side effects. Twelve newborn infants with mean 31.8 ± 3.5 weeks gestational age and median 1482 (810 - 3200) gram birth weight were included. 11/12 (91.7%) patients showed microbiological clearance with intravenous colistin. One patient who had recurrent cerebrospinal fluid positive culture was treated with intraventricular colistin. The major side effects observed was hyponatremia and hypokalemia in 2 (16.6%) patients, all infants required magnesium supplementation. CONCLUSIONS: Intravenous colistin administration appears to be safe and efficacious for multidrug-resistant gram-negative infections in neonates, including preterm infants. However, we believe that large prospective controlled studies are needed to confirm its efficacy and safety in neonates. |
format | Online Article Text |
id | pubmed-4575804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-45758042015-09-22 Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis Serafettin Tekgunduz, Kadir Kara, Mustafa Caner, Ibrahim Demirelli, Yasar Iran J Pediatr Research Article BACKGROUND: Although it is well described among adults, intravenous colistin use and its associated toxicities in newborns are poorly understood. OBJECTIVES: We present our experience of efficacy and safety of intravenous colistin in the treatment of sepsis in term and preterm neonates. PATIENTS AND METHODS: The records of neonates who received colistin between January 2013 and February 2014 were retrospectively reviewed. All neonates with culture proven nosocomial infections due to multidrug resistant organisms and treated continuously with colistin for more than 72 hours were included in the study. RESULTS: Patients were evaluated for clinical and microbiological response to the drug and its and side effects. Twelve newborn infants with mean 31.8 ± 3.5 weeks gestational age and median 1482 (810 - 3200) gram birth weight were included. 11/12 (91.7%) patients showed microbiological clearance with intravenous colistin. One patient who had recurrent cerebrospinal fluid positive culture was treated with intraventricular colistin. The major side effects observed was hyponatremia and hypokalemia in 2 (16.6%) patients, all infants required magnesium supplementation. CONCLUSIONS: Intravenous colistin administration appears to be safe and efficacious for multidrug-resistant gram-negative infections in neonates, including preterm infants. However, we believe that large prospective controlled studies are needed to confirm its efficacy and safety in neonates. Kowsar 2015-08-24 2015-08 /pmc/articles/PMC4575804/ /pubmed/26396706 http://dx.doi.org/10.5812/ijp.453 Text en Copyright © 2015, Growth & Development Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Research Article Serafettin Tekgunduz, Kadir Kara, Mustafa Caner, Ibrahim Demirelli, Yasar Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis |
title | Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis |
title_full | Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis |
title_fullStr | Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis |
title_full_unstemmed | Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis |
title_short | Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis |
title_sort | safety and efficacy of intravenous colistin in neonates with culture proven sepsis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575804/ https://www.ncbi.nlm.nih.gov/pubmed/26396706 http://dx.doi.org/10.5812/ijp.453 |
work_keys_str_mv | AT serafettintekgunduzkadir safetyandefficacyofintravenouscolistininneonateswithcultureprovensepsis AT karamustafa safetyandefficacyofintravenouscolistininneonateswithcultureprovensepsis AT caneribrahim safetyandefficacyofintravenouscolistininneonateswithcultureprovensepsis AT demirelliyasar safetyandefficacyofintravenouscolistininneonateswithcultureprovensepsis |